$9 million NIH grant advances drug to treat nicotine addiction

Funding awarded to scientists at Camino Pharma, Sanford Burnham Prebys, and UC San Diego will expand the nonclinical studies to support Phase 2 clinical evaluation SAN DIEGO, Feb. 6, 2024 /PRNewswire/ — Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks